Emily
Editor, Senior Moderator
https://www.haaretz.com/israel-news...-19-vaccine-research-institute-says-1.9338501
Israel to Produce 15 Million Doses of Its COVID-19 Vaccine, Research Institute Says
The third and final phase of testing on Israel's single-dose vaccine is expected to begin in April, says the director of the Institute for Biological Research
do Efrati
Nov. 30, 2020
The coronavirus vaccine being developed by the Israel Institute for Biological Research in Nes Tziona will require only one dose, not two like those being developed by Moderna and Pfizer, the center’s director general told lawmakers Monday.
....
The focus is on the safety of the vaccine. Shapira said the volunteers in the trial suffered “very minor” side effects. Phase 2 of the trial could begin in a week to 10 days, he said, “if we don’t encounter unnecessary delays.” That stage will have 960 participants and the third, some 30,000 participants.
Shapira added that the Israeli vaccine “has a scientific foot firmly on the ground, it’s not a new RNA vaccine.” He was referring to the fact that both Pfizer and Moderna’s vaccines trigger an immune response using messenger RNA, a method which has never been previously approved for use in vaccines.
“We don’t own stock and we have no economic consideration in our vaccines, just the good of Israeli citizens,” he said. “Scientific truth will triumph. People will understand that there is proper scientific interest here and people will believe in our vaccine.”...
Israel to Produce 15 Million Doses of Its COVID-19 Vaccine, Research Institute Says
The third and final phase of testing on Israel's single-dose vaccine is expected to begin in April, says the director of the Institute for Biological Research
do Efrati
Nov. 30, 2020
The coronavirus vaccine being developed by the Israel Institute for Biological Research in Nes Tziona will require only one dose, not two like those being developed by Moderna and Pfizer, the center’s director general told lawmakers Monday.
....
The focus is on the safety of the vaccine. Shapira said the volunteers in the trial suffered “very minor” side effects. Phase 2 of the trial could begin in a week to 10 days, he said, “if we don’t encounter unnecessary delays.” That stage will have 960 participants and the third, some 30,000 participants.
Shapira added that the Israeli vaccine “has a scientific foot firmly on the ground, it’s not a new RNA vaccine.” He was referring to the fact that both Pfizer and Moderna’s vaccines trigger an immune response using messenger RNA, a method which has never been previously approved for use in vaccines.
“We don’t own stock and we have no economic consideration in our vaccines, just the good of Israeli citizens,” he said. “Scientific truth will triumph. People will understand that there is proper scientific interest here and people will believe in our vaccine.”...